Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$730M |
| 3 |
Apple
AAPL
|
+$706M |
| 4 |
Walmart Inc
WMT
|
+$391M |
| 5 |
Alibaba
BABA
|
+$381M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 2 |
Hilton Worldwide
HLT
|
+$613M |
| 3 |
British American Tobacco
BTI
|
+$491M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$475M |
| 5 |
AABA
Altaba Inc
AABA
|
+$418M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.23% |
| 2 | Technology | 10.01% |
| 3 | Healthcare | 8.22% |
| 4 | Consumer Discretionary | 7.8% |
| 5 | Industrials | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5776
Lineage Cell Therapeutics
LCTX
$264M
| $64K | ﹤0.01% |
34,128
-12,410
| -27% | -$27.1K |
|
|
AENZ
5777
DELISTED
Aenza S.A.A.
AENZ
| $64K | ﹤0.01% |
+7,448
| New | +$84.4K |
|
5778
Matinas BioPharma
MTNB
$1.91M
| $63K | ﹤0.01% |
1,091
+690
| +172% | +$44.4K |
|
|
MDSO
5779
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
| $63K | ﹤0.01% |
+1,000
| New | +$71.2K |
|
5780
PUT
Crown Holdings
CCK
$13B
| $62K | ﹤0.01% |
+1,100
| New | +$65.1K |
|
5781
CALL
Stryker
SYK
$135B
| $62K | ﹤0.01% |
400
-2,300
| -85% | -$351K |
|
5782
CALL
Vanda Pharmaceuticals
VNDA
$304M
| $62K | ﹤0.01% |
4,100
-69,300
| -94% | -$1.03M |
|
|
CASI
5783
DELISTED
CASI Pharmaceuticals
CASI
| $61K | ﹤0.01% |
+1,886
| New | +$51.2K |
|
5784
CALL
HealthEquity
HQY
$8.71B
| $61K | ﹤0.01% |
1,300
-800
| -38% | -$39.6K |
|
5785
CALL
Zillow
ZG
$7.85B
| $61K | ﹤0.01% |
1,500
-3,900
| -72% | -$160K |
|
|
AMRS
5786
DELISTED
Amyris Inc.
AMRS
| $61K | ﹤0.01% |
16,136
-13,399
| -45% | -$45.1K |
|
|
CVRR
5787
PUT
DELISTED
CVR Refining, LP
CVRR
| $61K | ﹤0.01% |
3,700
-1,000
| -21% | -$12.3K |
|
5788
PUT
Cimpress
CMPR
$2.37B
| $60K | ﹤0.01% |
500
-200
| -29% | -$22.9K |
|
5789
PUT
Jones Lang LaSalle
JLL
$15.8B
| $60K | ﹤0.01% |
400
-1,100
| -73% | -$155K |
|
5790
CALL
iShares MSCI China ETF
MCHI
$6.23B
| $60K | ﹤0.01% |
900
-200
| -18% | -$13.2K |
|
5791
CALL
Rapid7
RPD
$628M
| $60K | ﹤0.01% |
3,200
-2,900
| -48% | -$53.7K |
|
|
ZOES
5792
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $60K | ﹤0.01% |
3,600
-100
| -3% | -$1.4K |
|
|
WLB
5793
DELISTED
Westmoreland Coal Company
WLB
| $60K | ﹤0.01% |
49,476
+37,167
| +302% | +$63.9K |
|
|
CVSA
5794
CALL
Covista Inc
CVSA
$4.55B
| $59K | ﹤0.01% |
1,400
+1,000
| +250% | +$39.2K |
|
5795
CALL
Harmony Gold Mining
HMY
$9.7B
| $59K | ﹤0.01% |
31,700
-2,800
| -8% | -$5.01K |
|
5796
PUT
Norwegian Cruise Line
NCLH
$9.53B
| $59K | ﹤0.01% |
1,100
-800
| -42% | -$44.3K |
|
5797
CALL
Quanta Services
PWR
$84.2B
| $59K | ﹤0.01% |
1,500
-7,300
| -83% | -$274K |
|
|
ONDK
5798
CALL
DELISTED
On Deck Capital, Inc.
ONDK
| $59K | ﹤0.01% |
10,200
+9,800
| +2,450% | +$50.3K |
|
|
MNTA
5799
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $59K | ﹤0.01% |
4,200
-5,400
| -56% | -$73K |
|
5800
CALL
CME Group
CME
$95.4B
| $58K | ﹤0.01% |
400
-233,900
| -100% | -$33.3M |
|
Similar funds
Goldman Sachs's Q4 2017 Portfolio in Review
As of Q4 2017, Goldman Sachs held 7,002 positions worth $418B, up 2.4% from $408B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q4 2017 filing shows 382 new, 2,273 increased, 3,347 reduced and 699 closed positions. Its largest new stake was Golden Entertainment: 4,030,636 shares worth $132M. The largest sale was iShares Russell 2000 ETF, an estimated $655M.
By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.6% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q4 2017 buy was Golden Entertainment: 4,030,636 shares worth $132M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.61B increase.
- Goldman Sachs's biggest Q4 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $655M.
- Goldman Sachs fully exited CR Bard Inc. in Q4 2017, selling an estimated $368M.
- Goldman Sachs's ten largest holdings make up 16% of its $418B portfolio in Q4 2017.
- Goldman Sachs opened 382 new positions and closed 699 in Q4 2017.
- Goldman Sachs's portfolio value rose 2.4% quarter-over-quarter to $418B.
Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.